Skip to main content
. Author manuscript; available in PMC: 2019 Jan 1.
Published in final edited form as: Am J Kidney Dis. 2017 Aug 9;71(1):27–34. doi: 10.1053/j.ajkd.2017.06.017

Table 3.

Association of baseline deoxycholic acid > 58 ng/mL with baseline BMD (n = 112)

β estimate (95% CI) P
Unadjusted −26.0 (−43.1 to −8.9) 0.004
Model 1 −19.0 (−35.1 to −2.9) 0.02
Model 2 −16.4 (−31.9 to −0.9) 0.04
Model 3 −16.1 (−31.6 to −0.6) 0.05
Model 4 −17.0 (−33.1 to −0.9) 0.04
Model 5 −20.3 (−39.1 to −1.5) 0.04

Note: n=112. 58 ng/mL is median level of deoxycholic acid. Model 1: unadjusted model + age; Model 2: model 1 + sex, race, body mass index, diabetes mellitus, hypertension, coronary artery disease; Model 3: model 2 + estimated glomerular filtration rate; Model 4: model 3 + calcium, phosphate; and Model 5: model 4 + intact parathyroid hormone, fibroblast growth factor 23.

BMD, bone mineral density; CI, confidence interval